1. Home
  2. SLNO vs KGS Comparison

SLNO vs KGS Comparison

Compare SLNO & KGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • KGS
  • Stock Information
  • Founded
  • SLNO 1999
  • KGS 2011
  • Country
  • SLNO United States
  • KGS United States
  • Employees
  • SLNO N/A
  • KGS N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KGS
  • Sector
  • SLNO Health Care
  • KGS
  • Exchange
  • SLNO Nasdaq
  • KGS Nasdaq
  • Market Cap
  • SLNO 3.8B
  • KGS 3.2B
  • IPO Year
  • SLNO 2014
  • KGS 2023
  • Fundamental
  • Price
  • SLNO $49.71
  • KGS $33.06
  • Analyst Decision
  • SLNO Strong Buy
  • KGS Strong Buy
  • Analyst Count
  • SLNO 10
  • KGS 9
  • Target Price
  • SLNO $112.50
  • KGS $42.56
  • AVG Volume (30 Days)
  • SLNO 1.7M
  • KGS 1.9M
  • Earning Date
  • SLNO 11-05-2025
  • KGS 11-05-2025
  • Dividend Yield
  • SLNO N/A
  • KGS 5.46%
  • EPS Growth
  • SLNO N/A
  • KGS 53.07
  • EPS
  • SLNO N/A
  • KGS 0.93
  • Revenue
  • SLNO $32,656,999.00
  • KGS $1,286,651,000.00
  • Revenue This Year
  • SLNO N/A
  • KGS $15.67
  • Revenue Next Year
  • SLNO $175.39
  • KGS $5.74
  • P/E Ratio
  • SLNO N/A
  • KGS $35.31
  • Revenue Growth
  • SLNO N/A
  • KGS 31.01
  • 52 Week Low
  • SLNO $41.50
  • KGS $26.21
  • 52 Week High
  • SLNO $90.32
  • KGS $50.43
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 22.26
  • KGS 42.29
  • Support Level
  • SLNO $50.63
  • KGS $32.57
  • Resistance Level
  • SLNO $72.99
  • KGS $33.75
  • Average True Range (ATR)
  • SLNO 4.32
  • KGS 0.89
  • MACD
  • SLNO -1.60
  • KGS -0.35
  • Stochastic Oscillator
  • SLNO 3.34
  • KGS 12.31

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About KGS Kodiak Gas Services Inc.

Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Contract Services and Other Services. Contract Services consists of operating Company-owned and customer-owned compression, and gas treating and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings.

Share on Social Networks: